Certain Hormone Linked to Poor Outcomes for Early-Stage Chronic Kidney Disease

Patients in the early stages of chronic kidney disease who had elevated levels of the endocrine hormone fibroblast growth factor 23 (that regulates phosphorus metabolism) had an associated increased risk of end-stage renal disease and death, according to a study in the June 15 issue of JAMA.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews